- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Kent Thiry on Creating Reimbursement Stability in Medicare Advantage
Medicare Advantage has the potential to be the most powerful part of the solution for American healthcare, but the government needs to create reimbursement stability in order for that to happen, said Kent Thiry, chief executive officer of DaVita Healthcare Partners Inc.
Medicare Advantage (MA) has the potential to be the most powerful part of the solution for American healthcare, but the government needs to create reimbursement stability in order for that to happen, Kent Thiry, chief executive officer of DaVita Healthcare Partners Inc, said at America’s Health Insurance Plans’ National Health Policy Conference in Washington, DC, March 11-12.
Studies have shown that when MA becomes a large part of providers’ business, they change how they do all business, which shows how the MA program can be a strategic asset for the country. However, it needs to be nurtured, he said.
“We need reimbursement stability and certainty in order to unleash the forces of innovation,” Mr Thiry said.
Managed Care Reflections: A Q&A With Charles N. (Chip) Kahn III, MPH
July 30th 2025To mark the 30th anniversary of The American Journal of Managed Care (AJMC), each issue in 2025 includes a special feature: reflections from a thought leader on what has changed—and what has not—over the past 3 decades and what’s next for managed care. The August issue features a conversation with Charles N. (Chip) Kahn III, MPH, the president and CEO of the Federation of American Hospitals and a longtime member of the AJMC editorial board.
Read More
It Take a Village in Cancer Care: A Q&A With David Nguyen, MD
July 23rd 2025David Nguyen, MD, medical oncologist with Tufts Medicine and Lowell General Hospital, discusses the evolving landscape of advanced cancer treatments like chimeric antigen receptor T-cell therapy and bispecific antibodies
Read More
Effects of Adjunctive Cariprazine Formulary Restrictions in Major Depressive Disorder
July 23rd 2025Patients who experienced a formulary-related rejection of cariprazine for adjunctive treatment of major depressive disorder had significantly higher hospitalization rates than those with approved claims.
Read More
